Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Enterococcus faecium R0026 and Improved Gastrointestinal Symptoms

Research synthesisVery low evidenceMixed effect size3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial effects on gastrointestinal symptoms, with effect sizes ranging from small to moderate. The evidence is limited to systematic reviews and narrative reviews in athletic and general adult populations, with no dose or duration data available. The predominant effect size is mixed (small to moderate) across studies.

  • Studied populations: athletes, adult humans

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. None of the included studies reported statistical significance, and no dose, form, or duration data were extracted, limiting the specificity of findings. The beneficial effects are drawn from broad probiotic reviews that include multiple strains, so the independent effect of Enterococcus faecium R0026 specifically is not isolated. Available evidence is overwhelmingly positive — publication bias may overstate benefits (null-result studies less likely to be indexed).

Generated Jun 11, 2026
3 of 3 papers
Back to top